Skip to content

Natvarlal Rajpara, MD

NPI 1629065305ActiveIndividual· Internal Medicine, Pulmonary Disease· Westminster, MD

Internal Medicine, Pulmonary Disease (MD) in Westminster, Maryland, licensed in MD and HI, with an NPI issued in September 2005. Part D covered 683 prescriptions written in 2024, 40% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 2 companies reporting payments in 2025, $113.02 in all, mostly food and beverage.

Overview

NPI1629065305
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedSep 29, 2005
Last updated in NPPESMay 1, 2025
Certified by providerMay 1, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Pulmonary Disease (DC); Practitioner - Pulmonary Disease (HI); Practitioner - Hospitalist (MD); Practitioner - Internal Medicine (TX)

Part D prescriptions in 2024

Prescriptions (claims)683 · 829 30-day fills
Patients139
Total drug cost$546,999
Generic share40% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$113.02 · 3 payments from 2 companies
  • 2024$68.91 · 1 payment from 1 company

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$113.02 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other pulmonologists in Westminster

All pulmonologists in Maryland